INSIGHT REPORT CALENDAR

NEWSLETTER

Like this article?

Sign up to our free newsletter

HIG Capital completes acquisition of Taconic Biosciences

An affiliate of HIG Capital (HIG) has partnered with the management team of Taconic Biosciences to acquire the company.

Headquartered in Rensselaer, NY, with operations in Germantown, NY, Indiana, Germany, and Denmark, Taconic is a specialist in genetically engineered models and service solutions used in mission-critical life sciences research. With its strong market position and long-standing relationships, Taconic is well-positioned to benefit from the significant growth in the broader healthcare services market and more specifically in genetically engineered models growth. Researchers use Taconic’s models and services in a wide variety of growing research applications, including oncology, immunology, and neuroscience, as well as other established and emerging therapeutic areas.
 
“Taconic’s scientific expertise, customer-first mentality, outstanding quality and service standards, and full suite of capabilities provide a differentiated end-to-end solution that offers unique value to the growing life sciences market,” says John Von Bargen, a Managing Director at HIG “We are excited to support Taconic’s exceptional leadership team as they look to expand the Company’s geographic footprint, partnership base, and product and service offerings.”
 
Former CEO Dr. Robert Rosenthal was named Chairman of Taconic’s Board of Directors as well as the Company’s Chief Innovation Officer, helping guide the Company’s strategic direction. Also joining the board is Alex Zisson, a Managing Director of HIG BioHealth Partners, the dedicated life-science investment affiliate of HIG. Alex has spent over two decades in the healthcare investment and research industries covering biotechnology, specialty pharmaceuticals, drug delivery, and diagnostics industries.
 
“Taconic Biosciences is at a very exciting point in its growth trajectory. We are confident the partnership with HIG positions us to continue delivering world-class problem solving solutions to our customers, while providing the resources required to achieve our strategic plan,” says Dr. Robert Rosenthal. Nancy Sandy, Taconic’s new Chief Executive Officer added, “HIG’s investment and deep resources, particularly around M&A, will help catalyse our continued expansion and allow us to more quickly address unmet customer needs.”

Like this article? Sign up to our free newsletter

FEATURED

Tech Stocks

MOST RECENT

FURTHER READING